Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 8 matching records.
8 results — page 1 of 1
- Level DAnimal StudyPubMed
Foxk2 Enhances Adipogenic Differentiation by Relying on the Transcriptional Activation of Peroxisome Proliferator-Activated Receptor Gamma.
Animal Study, published in J Cell Mol Med (2025) — summary generated from the PubMed abstract.
- 2025
J Cell Mol Med - Level DAnimal StudyEurope PMC
Radish Seed Exerts Anti-Diabetic and Obesity-Reducing Effects in Mice by Promoting the Activation of Uncoupling Protein 1 and Peroxisome Proliferator-Activated Receptor-γ Coactivator 1-α
Animal Study on Type 2 Diabetes, published in J Evid Based Integr Med (2025) — summary generated from the PubMed abstract.
- 2025
J Evid Based Integr Med - Level DAnimal StudyPubMed
A Novel Peroxisome Proliferator-Activated Receptor Gamma/Nuclear Factor-Kappa B Activation Pathway is Involved in the Protective Effect of Adipose-Derived Mesenchymal Stem Cells Against Ischemia-Reperfusion Lung Injury.
Animal Study, published in Transplant Proc (2024) — summary generated from the PubMed abstract.
- 2024
Transplant Proc - Level DAnimal StudyPubMed
Bisphenol S- and bisphenol A-induced adipogenesis of murine preadipocytes occurs through direct peroxisome proliferator-activated receptor gamma activation.
Animal Study on Hip, published in Int J Obes (Lond) (2016) — summary generated from the PubMed abstract.
- 2016
Int J Obes (Lond) - Level DAnimal StudyEurope PMC
Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes
Animal Study on Type 2 Diabetes, published in J Lipid Res (2011) — summary generated from the PubMed abstract.
- 2011
J Lipid Res156 citations - Level DLaboratory StudyPubMed
Activation of peroxisome proliferator-activated receptor-α enhances fatty acid oxidation in human adipocytes.
Laboratory Study on Type 2 Diabetes, published in Biochem Biophys Res Commun (2011) — summary generated from the PubMed abstract.
- 2011
Biochem Biophys Res Commun36 citations - Level CProspective StudyPubMed
Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo.
Prospective Study, published in Endocrinology (2006) — summary generated from the PubMed abstract.
- 2006
Endocrinology - Level DAnimal StudyPubMed
Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells.
Animal Study on Cardiovascular Disease, published in Mol Pharmacol (1996) — summary generated from the PubMed abstract.
- 1996
Mol Pharmacol
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406